J&J suing Samsung Bioepis over Stelara biosimilar (update)
Johnson & Johnson (NYSE:JNJ) is suing Samsung Bioepis for breach of contract related to the launch of a biosimilar of J&J's ...
Atlanta Journal-Constitution5h
The Latest: 21 employees resign from DOGE, refusing to ‘dismantle critical public services’
More than 20 civil service employees resigned Tuesday from Elon Musk's Department of Government Efficiency, saying they refused to use their technical expertise to "dismantle critical public services.
The Latest: Musk renews threat to fire federal workers despite pushback from various agencies
Elon Musk is vowing yet again to fire any federal workers who don’t respond to an email asking them to list five things they ...
Biocurious: With Mayne Pharmaceuticals under takeover offer, who’s next?
The ‘London’ Bus theory goes that if one takeover emerges in a particular sector, then others will follow in quick succession ...
centerforbiosimilars20h
3 Ustekinumab Biosimilars Launch on US Market
Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...
STAT21h
J&J sues Samsung over a contract breach for a Stelara biosimilar
As biosimilar versions of a big-selling Johnson & Johnson medicine reach the U.S. market, the health care giant accused one ...